<DOC>
	<DOCNO>NCT00718276</DOCNO>
	<brief_summary>We compare effect HyD ( 25-hydroxyvitamin D ) vitamin D3 effect 25-hydroxyvitamin D plasma level course 4 month . This pharmacokinetic study include 35 postmenopausal woman . - Trial medicinal product</brief_summary>
	<brief_title>Pharmacokinetic Study : Effect 25 ( OH ) D Vitamin D3 Serum 25 ( OH ) D</brief_title>
	<detailed_description>We include postmenopausal woman age 50 75 , race/ethnicity : Caucasian , serum 25 ( OH ) D baseline 20 60 nmol/l , body mass index : &lt; 30 kg/m2 compare 25 ( OH ) D vitamin D3 equimolar dos 4 month pharmacokinetic trial . The dosing arm daily , weekly , bolus</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Inclusion criterion : Postmenopausal woman Age 50 75 year Body mass index 1829 kg/m2 25hydroxyvitamin D level 20 60 nmol/l Caucasian Generally healthy Exclusion criterion : Serum calcium &gt; 2.6 nmol/L Use dietary supplement ( &gt; 400 IU vitamin D per day , &gt; 600 mg calcium per day ) Hypertension Diseases carry risk hypercalcemia Use drug interfere bone metabolism last 12 month ( bisphosphonates estrogen receptor modulators , PTH , calcitonin ) Oral HRT last 6 month Extreme diet Fracture fall last 3 month Current smoke alcohol abuse Planning sunny vacation course trial Kidney stone history Creatinine clearance &lt; 30 ml/min Comedications : anticoagulant , PTH , corticosteroid , thiazide diuretic , digoxin , anticonvulsant , malabsorption , z C</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Healthy postmenopausal woman</keyword>
</DOC>